BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT03682276 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-01 → 2026-03-12 3. primary completion date: 2023-09-01 → 2026-03-12 4. enrollment: 32 → 33 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical